Complications and 30-day Outcomes Associated With Venous Thromboembolism in the Pediatric Orthopaedic Surgical Population

被引:30
作者
Baker, Dustin [1 ]
Sherrod, Brandon [1 ]
McGwin, Gerald, Jr. [2 ]
Ponce, Brent [1 ]
Gilbert, Shawn [1 ,3 ]
机构
[1] Univ Alabama Birmingham, Dept Surg, Div Orthopaed Surg, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA
[3] Childrens Hosp Alabama, Birmingham, AL USA
关键词
venous thromboembolism; deep vein thrombosis; pulmonary embolism; pediatric orthopaedics; National Surgical Quality Improvement Program; morbidity; DEEP-VEIN THROMBOSIS; QUALITY IMPROVEMENT PROGRAM; CRITICALLY-ILL CHILDREN; RISK-FACTORS; PULMONARY-EMBOLISM; UNITED-STATES; AMERICAN-COLLEGE; CARE; HYPONATREMIA; PROPHYLAXIS;
D O I
10.5435/JAAOS-D-15-00481
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Introduction: The risk of morbidity associated with venous thromboembolism (VTE) after pediatric orthopaedic surgery remains unclear despite increased use of thromboprophylaxis measures.Methods: The American College of Surgeons National Surgical Quality Improvement Program, Pediatric database was queried for patients undergoing an orthopaedic surgical procedure between 2012 and 2013. Upper extremity and skin/subcutaneous surgeries were excluded. Associations between VTE and procedure, demographics, comorbidities, preoperative laboratory values, and 30-day postoperative outcomes were evaluated.Results: Of 14,776 cases, 15 patients (0.10%) experienced postoperative VTE. Deep vein thrombosis (DVT) occurred in 13 patients (0.09%), and pulmonary embolism developed in 2 patients (0.01%). The procedure with the highest VTE rate was surgery for infection (1.2%). Patient factors associated with the development of VTE included hyponatremia (P = 0.003), abnormal partial thromboplastin time (P = 0.046), elevated aspartate transaminase level (P = 0.004), and gastrointestinal (P = 0.011), renal (P = 0.016), and hematologic (P = 0.019) disorders. Nearly half (46.2%) of DVTs occurred postdischarge. Complications associated with VTE included prolonged hospitalization (P < 0.001), pneumonia (P < 0.001), unplanned intubation (P = 0.003), urinary tract infection (P = 0.003), and central line-associated bloodstream infection (P < 0.001). Most of the postoperative complications (66.7%) occurred before VTE diagnosis, and no patients with VTE died.Conclusion: In the absence of specified risk factors, thromboprophylaxis may be unnecessary for this population.
引用
收藏
页码:196 / 206
页数:11
相关论文
共 40 条
[11]   Thromboembolic Complications in Children After Spinal Fusion Surgery [J].
Jain, Amit ;
Karas, Dominique J. ;
Skolasky, Richard L. ;
Sponseller, Paul D. .
SPINE, 2014, 39 (16) :1325-1329
[12]   Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis A Systematic Review [J].
Januel, Jean-Marie ;
Chen, Guanmin ;
Ruffieux, Christiane ;
Quan, Hude ;
Douketis, James D. ;
Crowther, Mark A. ;
Colin, Cyrille ;
Ghali, William A. ;
Burnand, Bernard .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (03) :294-303
[13]   Healthcare burden of venous thromboembolism in childhood chronic renal diseases [J].
Kerlin, Bryce A. ;
Smoyer, William E. ;
Tsai, James ;
Boulet, Sheree L. .
PEDIATRIC NEPHROLOGY, 2015, 30 (05) :829-837
[14]   Current and future management of pediatric venous thromboembolism [J].
Kerlin, Bryce A. .
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 :S68-S74
[15]  
Korkmaz I, 2013, J PAK MED ASSOC, V63, P331
[16]   A Guide to the Use of Anticoagulant Drugs in Children [J].
Law, Connie ;
Raffini, Leslie .
PEDIATRIC DRUGS, 2015, 17 (02) :105-114
[17]   Hemostasis and thrombosis in patients with liver disease: The ups and downs [J].
Lisman, Ton ;
Caldwell, Stephen H. ;
Burroughs, Andrew K. ;
Northup, Patrick G. ;
Senzolo, Marco ;
Stravitz, R. Todd ;
Tripodi, Armando ;
Trotter, James F. ;
Valla, Dominique-Charles ;
Porte, Robert J. .
JOURNAL OF HEPATOLOGY, 2010, 53 (02) :362-371
[18]   Deep-vein thrombosis: A United States cost model for a preventable and costly adverse event [J].
Mahan, Charles E. ;
Holdsworth, Mark T. ;
Welch, Shawn M. ;
Borrego, Matt ;
Spyropoulos, Alex C. .
THROMBOSIS AND HAEMOSTASIS, 2011, 106 (03) :405-415
[19]   An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial [J].
Massicotte, P ;
Julian, JA ;
Gent, M ;
Shields, K ;
Marzinotto, V ;
Szechtman, B ;
Andrew, M .
THROMBOSIS RESEARCH, 2003, 109 (2-3) :85-92
[20]   Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry [J].
Monagle, P ;
Adams, M ;
Mahoney, M ;
Ali, K ;
Barnard, D ;
Bernstein, M ;
Brisson, L ;
David, M ;
Desai, S ;
Scully, MF ;
Halton, J ;
Israels, S ;
Jardine, L ;
Leaker, M ;
McCusker, P ;
Silva, M ;
Wu, J ;
Anderson, R ;
Andrew, M ;
Massicotte, MP .
PEDIATRIC RESEARCH, 2000, 47 (06) :763-766